vancomycin has been researched along with 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
Anton, PM; Eisenstein, B; Kelly, CP; Kokkotou, E; Michaelis, A; O'Brien, M; Paraschos, S; Pothoulakis, C; Rothstein, D | 1 |
Farquhar, R; Murphy, CK; Osburne, MS; Rothstein, DM | 1 |
4 other study(ies) available for vancomycin and 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin
Article | Year |
---|---|
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Enzyme-Linked Immunosorbent Assay; Mesocricetus; Microbial Sensitivity Tests; Rifamycins; Secondary Prevention; Survival Analysis; Vancomycin; Weight Loss | 2004 |
In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus; Time Factors; Vancomycin | 2006 |